Sonia Pawluczyk, MD

Title(s)Clinical Assistant Professor of Psychiatry & the Behavioral Sciences (Part-Time)
SchoolKeck School of Medicine of Usc
AddressHCT 3000 1520 San Pablo Street
Health Sciences Campus
Los Angeles CA 90089-9409
Phone+1 323 442 7600
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Dr. Pawluczyk was born in Buenos Aires, Argentina. After receiving her MD diploma at the Medical School of the University of Buenos Aires, she completed the “Curso Superior de Psiquiatria” at Hospital Borda. She moved to Los Angeles and entered the residency training in Psychiatry at LAC+USC. She did a fellowship in Psychiatry and the Law and in Geriatric Psychiatry. She then joined the Department of Psychiatry and has been part of the Geriatric Studies Center since 1991. Dr. Pawluczyk practices at the Memory and Aging Center at USC and she is also a consultant at Rancho Los Amigos Hospital. Dr. Pawluczyk is fluent in Spanish.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Safety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: A single and multiple ascending dose phase 1b/2a clinical trial. Alzheimers Dement (N Y). 2020; 6(1):e12107. Hernandez GD, Solinsky CM, Mack WJ, Kono N, Rodgers KE, Wu CY, Mollo AR, Lopez CM, Pawluczyk S, Bauer G, Matthews D, Shi Y, Law M, Rogawski MA, Schneider LS, Brinton RD. PMID: 33344752; PMCID: PMC7744018.
      View in: PubMed   Mentions: 4  
    2. Safety and feasibility of estrogen receptor-β targeted phytoSERM formulation for menopausal symptoms: phase 1b/2a randomized clinical trial. Menopause. 2019 08; 26(8):874-884. Schneider LS, Hernandez G, Zhao L, Franke AA, Chen YL, Pawluczyk S, Mack WJ, Brinton RD. PMID: 30889096; PMCID: PMC6663614.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    3. Evaluation of Medicare Claims Data as a Tool to Identify Dementia. J Alzheimers Dis. 2019; 67(2):769-778. Lee E, Gatz M, Tseng C, Schneider LS, Pawluczyk S, Wu AH, Deapen D. PMID: 30689589; PMCID: PMC7164318.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    4. Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial. Am J Psychiatry. 2016 May 01; 173(5):465-72. Schneider LS, Frangakis C, Drye LT, Devanand DP, Marano CM, Mintzer J, Mulsant BH, Munro CA, Newell JA, Pawluczyk S, Pelton G, Pollock BG, Porsteinsson AP, Rabins PV, Rein L, Rosenberg PB, Shade D, Weintraub D, Yesavage J, Lyketsos CG, CitAD Research Group. PMID: 26771737; PMCID: PMC6419726.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    5. Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A. 2012 Mar 06; 109(10):3985-90. Bakken TE, Roddey JC, Djurovic S, Akshoomoff N, Amaral DG, Bloss CS, Casey BJ, Chang L, Ernst TM, Gruen JR, Jernigan TL, Kaufmann WE, Kenet T, Kennedy DN, Kuperman JM, Murray SS, Sowell ER, Rimol LM, Mattingsdal M, Melle I, Agartz I, Andreassen OA, Schork NJ, Dale AM, Alzheimer's Disease Neuroimaging Initiative, Pediatric Imaging, Neurocognition, and Genetics Study, Weiner M, Aisen P, Petersen R, Jack CR, Jagust W, Trojanowki JQ, Toga AW, Beckett L, Green RC, Saykin AJ, Morris J, Liu E, Montine T, Gamst A, Thomas RG, Donohue M, Walter S, Gessert D, Sather T, Harvey D, Kornak J, Dale A, Bernstein M, Felmlee J, Fox N, Thompson P, Schuff N, Alexander G, DeCarli C, Bandy D, Koeppe RA, Foster N, Reiman EM, Chen K, Mathis C, Cairns NJ, Taylor-Reinwald L, Trojanowki JQ, Shaw L, Lee VM, Korecka M, Crawford K, Neu S, Foroud TM, Potkin S, Shen L, Kachaturian Z, Frank R, Snyder PJ, Molchan S, Kaye J, Quinn J, Lind B, Dolen S, Schneider LS, Pawluczyk S, Spann BM, Brewer J, Vanderswag H, Heidebrink JL, Lord JL, Johnson K, Doody RS, Villanueva-Meyer J, Chowdhury M, Stern Y, Honig LS, Bell KL, Morris JC, Ances B, Carroll M, Leon S, Mintun MA, Schneider S, Marson D, Griffith R, Clark D, Grossman H, Mitsis E, Romirowsky A, deToledo-Morrell L, Shah RC, Duara R, Varon D, Roberts P, Albert M, Onyike C, Kielb S, Rusinek H, de Leon MJ, Glodzik L, De Santi S, Doraiswamy PM, Petrella JR, Coleman RE, Arnold SE, Karlawish JH, Wolk D, Smith CD, Jicha G, Hardy P, Lopez OL, Oakley M, Simpson DM, Porsteinsson AP, Goldstein BS, Martin K, Makino KM, Ismail MS, Brand C, Mulnard RA, Thai G, Mc-Adams-Ortiz C, Womack K, Mathews D, Quiceno M, Diaz-Arrastia R, King R, Weiner M, Martin-Cook K, DeVous M, Levey AI, Lah JJ, Cellar JS, Burns JM, Anderson HS, Swerdlow RH, Apostolova L, Lu PH, Bartzokis G, Silverman DH, Graff-Radford NR, Parfitt F, Johnson H, Farlow MR, Hake AM, Matthews BR, Herring S, van Dyck CH, Carson RE, MacAvoy MG, Chertkow H, Bergman H, Hosein C, Black S, Stefanovic B, Caldwell C, Hsiung R, Feldman H, Mudge B, Assaly M, Kertesz A, Rogers J, Trost D, Bernick C, Munic D, Kerwin D, Mesulam MM, Lipowski K, Wu CK, Johnson N, Sadowsky C, Martinez W, Villena T, Turner RS, Johnson K, Reynolds B, Sperling RA, Johnson KA, Marshall G, Frey M, Yesavage J, Taylor JL, Lane B, Rosen A, Tinklenberg J, Sabbagh M, Belden C, Jacobson S, Kowall N, Killiany R, Budson AE, Norbash A, Johnson PL, Obisesan TO, Wolday S, Bwayo SK, Lerner A, Hudson L, Ogrocki P, Fletcher E, Carmichael O, et al. PMID: 22343285; PMCID: PMC3309762.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimals
    6. Spanish instrument protocol: new treatment efficacy instruments for Spanish-speaking patients in Alzheimer disease clinical trials. Alzheimer Dis Assoc Disord. 2006 Oct-Dec; 20(4):232-41. Sano M, Egelko S, Jin S, Cummings J, Clark CM, Pawluczyk S, Thomas RJ, Schittini M, Thal LJ, Alzheimer's Disease Cooperative Study Group. PMID: 17132967; PMCID: PMC3526370.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    7. A pilot randomized trial of carbamazepine for behavioral symptoms in treatment-resistant outpatients with Alzheimer disease. Am J Geriatr Psychiatry. 2001; 9(4):400-5. Olin JT, Fox LS, Pawluczyk S, Taggart NA, Schneider LS. PMID: 11739066.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCTClinical Trials
    8. The Spanish Instrument Protocol: design and implementation of a study to evaluate treatment efficacy Instruments for Spanish-speaking patients with Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997; 11 Suppl 2:S57-64. Sano M, Mackell JA, Ponton M, Ferreira P, Wilson J, Pawluczyk S, Pfeiffer E, Thomas RG, Jin S, Schafer K, Schittini M, Grundman M, Ferris SH, Thal LJ. PMID: 9236954.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    9. A double-blind crossover pilot study of l-deprenyl (selegiline) combined with cholinesterase inhibitor in Alzheimer's disease. Am J Psychiatry. 1993 Feb; 150(2):321-3. Schneider LS, Olin JT, Pawluczyk S. PMID: 8422085.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    10. Topographic quantitative EEG amplitude in recovered alcoholics. Psychiatry Res. 1992 May; 45(1):25-32. Pollock VE, Schneider LS, Zemansky MF, Gleason RP, Pawluczyk S. PMID: 1410076.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    11. Do blood pressure and age predict response to tacrine (THA) in Alzheimer's disease? A preliminary report. Psychopharmacol Bull. 1991; 27(3):309-14. Schneider LS, Lyness SA, Pawluczyk S, Gleason RP, Sloane RB. PMID: 1775604.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    12. Seizures following triazolam withdrawal despite benzodiazepine treatment. J Clin Psychiatry. 1987 Oct; 48(10):418-9. Schneider LS, Syapin PJ, Pawluczyk S. PMID: 2889721.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    Sonia's Networks
    Concepts (84)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (35)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version v3.1.0-871-g21b54b14 on PROFILES-PWEB02.